Evidence map›Paper›PMID 21300403›Full record

ReviewPlacenta2011

Review: Transport of maternal cholesterol to the fetal circulation.

L A Woollett

Open access · greenAbstract readReview
In one paragraph

Review in Placenta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 169 citations in OpenAlex.

  1. Trial
  2. Early atherogenesis: In search of etiology.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. MiRNAs: main players of cancer drug resistance target ABC transporters.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Evidence for hypoxia-induced dysregulated cholesterol homeostasis in preeclampsia: Insights into the mechanisms from human placental cells and tissues.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  14. Assessing Cholesterol Efflux on Primary Human Trophoblast Cells.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

L A WoollettUniversity of Cincinnati, Metabolic Diseases Institute, Department of Pathology, Cincinnati, OH 45236-507, USA. Laura.Woollett@uc.edu
University of Cincinnati · US

Funding

STEROL METABOLISM DURING PREGNANCY AND DEVELOPMENTR01HD034089 · NICHD · UNIVERSITY OF CINCINNATI · PI WOOLLETT, LAURA A · 1997 to 2005
$1.4M
Sterol Metabolism During Pregnancy and DevelopmentR56HD034089 · NICHD · UNIVERSITY OF CINCINNATI · PI WOOLLETT, LAURA A · 2008 to 2008
$298k
NICHD NIH HHS HD34089NICHD NIH HHS R01 HD034089NICHD NIH HHS R56 HD034089
6 · The paper itself

Abstract

Data obtained from recent studies in humans, rodents, and cell culture demonstrate that circulating maternal cholesterol can be transported to the fetus. The two major cell types responsible for the transport are trophoblasts and endothelial cells of the fetoplacental vasculature. Maternal lipoprotein-cholesterol is initially taken up by trophoblasts via receptor-mediated and receptor-independent processes, is transported by any number of the sterol transport proteins expressed by cells, and is effluxed or secreted out of the basal side via protein-mediated processes or by aqueous diffusion. This cholesterol is then taken up by the endothelium and effluxed to acceptors within the fetal circulation. The ability to manipulate the mass of maternal cholesterol that is taken up by the placenta and crosses to the fetus could positively impact development of fetuses affected with the Smith-Lemli-Opitz Syndrome (SLOS) that have reduced ability to synthesize cholesterol and possibly impact growth of fetuses unaffected by SLOS but with low birthweights.

Indexed as

AnimalsBiological TransportCholesterolFemaleFetusHumansMaternal-Fetal ExchangePregnancySmith-Lemli-Opitz SyndromeCholesterol

Identifiers

PMID21300403
PMCPMC4699659
OpenAlexW2052324612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.